Welcome to BioLegend’s one-of-a-kind advanced search. Search by any one of the single fields below or narrow down your searches by using multiple parameters. Looking for an anti-mouse NK cell antibody for IHC? Or looking for a FITC-conjugated antibody against a human marker for dendritic cells to use for flow cytometry? Only BioLegend’s advanced search can provide you with the best answers. If you have further questions, please contact our technical service team at 858-768-5801.
Use this document lookup tool to find Current Product Datasheets, Certificates of Analysis, or MSDS for any antibody products you have purchased from BioLegend.
Use the search box below to perform a site search of BioLegend.com powered by Google™.
Brefeldin A Solution (1,000X)
Brefeldin A Solution (1,000X)
420601
1 ml
$110.00
Product Details
Formulation:
Brefeldin A Solution is supplied as a 1000X in DMSO, which should be diluted to 1X in cell culture medium.
Dilute the 1000X solution to 1X in the tissue culture medium. It is recommended that cells are cultured with brefeldin A for ≤ 24 hours, as this can become toxic for cell viability.
COA:
Application References:
1. O'Sullivan BJ, et al. 2006. J. Immunol. 176:7278. 2. Fuse S, et al. 2007. J. Immunol. 178:5227. 3. Kang YJ, et al. 2007. Nature Immunol. 8:601. 4. Redfern CH,et al.2006.J. Clin Oncol.19:3107.PubMed 5. Smithey MJ, et al. 2008. J. Immunol. 180:3406. PubMed 6. Elzey BD, et al. 2008. Blood 111:38684. PubMed 7. Nguyen KD, et al. 2008. J. Immunol. 181:5386. PubMed 8. Goodridge HS, et al. 2009. J. Immunol. 182:1146. PubMed 9. Markey KA, et al. 2009. Blood 113:5644. PubMed 10. Wilcox RA, et al. 2009. Blood PubMed 11. Zenaro E, et al. 2009. J. Leukoc Bio. PubMed 12. Butcher JP, et al. 2010. Clin Cancer Res. 16:2065. PubMed 13. Boisvert M, et al. 2010. J. Virol. 84:7782. PubMed 14. Liu WC, et al. 2010. J. Virol. 84:12011. PubMed 15. Tawara I, et al. 2011. Clin Cancer Res. 17:77. PubMed 16. Iwata Y, et al. 2011. Blood 117:530. PubMed 17. Schmidt NW, et al. 2011. J. Immunol. 186:3836. PubMed
Description:
Brefeldin A (BFA) is a protein transport inhibitor commonly used to enhance intracellular cytokine staining signals by blocking transport processes during cell activation. Especially useful for the intracellular staining of cytokines, BFA leads to the accumulation of most cytokines at the Golgi Complex/Endoplasmic Reticulum (see Jung, et al., 1993). Optimal conditions for use are cell type and time-dependent. Typically, protein transport inhibitors are included during in vitro cell activation cultures for 4-24 hours prior to harvest (see references below for additional information). Brefeldin A Solution is supplied as a 1,000X solution, which should be diluted to 1X in cell culture medium.
Other Names:
BFA
Antigen References:
1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD). 2. Sander B, et al. 1991. Immunol. Rev. 119:65. 3. Sander B, et al. 1993. J. Immunol. Meth. 166:201. 4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117. 5. Jung T, et al. 1993. J. Immunol. Meth. 159:197.
*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/terms). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.
